Newsletter

Moderna CEO: “Vaccine effectiveness is negative”… The New York Stock Exchange fell immediately.

(Photo = Reuters/Yonhap News)

[뉴욕=이데일리 김정남 특파원] The New York Stock Exchange was lower in early trading on the 30th (local time). This is because concerns about the new corona 19 mutant virus, Omicron, have risen again.

According to Marketpoint, as of 9:43 a.m. on the same day, the Dow Jones Industrial Average, which collects blue chips on the New York Stock Exchange, was down 0.66% from the previous trading day. The S&P 500 index, which focuses on large-cap stocks, is down 0.60%.

The tech-focused Nasdaq is down 0.29%. As the 10-year US Treasury yield fell back to the low 1.4% range, the Nasdaq Index is doing well in the weak range.

The Chicago Options Exchange Volatility Index (VIX), also known as the Wall Street Fear Index, surged 8.14% to 24.83. This means that investor sentiment is shrinking again.

The same goes for international oil prices. On the New York Mercantile Exchange, the price of West Texas Intermediate (WTI) for January delivery has fallen more than 3% from the previous trading day, rising and falling in the mid-$67 range. This is a result of the market’s risk aversion tendency.

This is because investors are re-watching the omicron mutation risk. In particular, the negative remarks of Steve Bansel Moderna, Chief Executive Officer (CEO), had a significant impact.

In an interview with the Financial Times (FT), Bancel CEO said, “It is unlikely that existing vaccines against the omicron mutation will be as effective as the delta mutation.” Moderna co-founder Nuva Afeyan, chairman of the board, told Bloomberg that “we must accept the serious threat posed by the omicron mutant virus.”

Jim Paulson, chief investment strategist at the Reuttholt Group, said: “The market is focusing on news streams related to omicron mutations.” This means that the market volatility is increasing according to the news that comes out every moment.

.